Copellor 80mg Injection contains Ixekizumab, a monoclonal antibody used to treat autoimmune conditions, particularly moderate to severe plaque psoriasis and other inflammatory conditions.

Brand Name: Copellor

Composition: Ixekizumab

Mechanism of Action:

A monoclonal antibody called ixekizumab selectively targets the cytokine interleukin-17A (IL-17A), which is implicated in inflammation. Ixekizumab decreases inflammation and other symptoms linked to inflammatory diseases such as psoriasis, psoriatic arthritis, and ankylosing spondylitis by blocking IL-17A.

Uses:

Plaque Psoriasis

Dosage and Administration:

It is given as a subcutaneous injection. A healthcare professional should oversee its administration.

Side Effects:

• Pain
• Redness
• Swelling at the injection site
• Sore throat
• Sinus infections
• Runny nose
• Headache
• Fatigue
• Diarrhea
• Nausea
• Vomiting

Safety Advise:

Kidney  

Patients with severe renal disease should exercise caution while using Copellor Injection. Kindly speak with your healthcare provider.

Liver  

Copellor Injection should be administered with caution to individuals suffering from liver disease. Kindly speak with your healthcare provider.

Pregnancy  

Copellor Injection is not recommended for usage during pregnancy since there is clear evidence of danger to the developing infant. Kindly speak with your healthcare provider.

Breast Feeding  

Copellor Injection is not safe to use when breast feeding. Kindly speak with your healthcare provider.

Alcohol  

Copellor Injection of alcohol may produce extreme sleepiness. Kindly speak with your healthcare provider.

Storage:

Store in a refrigerator (2°C to 8°C). Do not freeze. Protect from light.

How to use this Medication?

Dosing schedules for ixekizumab, a subcutaneous injection used to treat non-radiographic axial spondyloarthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis, vary depending on the patient's weight and condition. Maintenance dosages are administered every two to four weeks after the initial one or two doses.

The initial dose of ixekizumab is typically administered at a physician's office; however, if taught, adults and caregivers may provide subsequent doses at home. For children under 110 pounds (50 kg), shots must be administered in a medical facility.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Eli Lilly and Company India Pvt Ltd

Address: Plot# 92, Sector 32, Institutional Area, Gurgaon-122001, HARYANA, INDIA

Country of origin: India